HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2006.075846v1 62/9/806    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeMeo, D. L Articles by Silverman, E. K Search for Related Content PubMed PubMed Citation Articles by DeMeo, D. L Articles by Silverman, E. K

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency

¹ Channing Laboratory, Brigham and Women’s Hospital, Boston, Massachusetts, USA
² National Jewish Medical and Research Center, Denver, Colorado, USA
³ Oregon Health and Science University, Portland, Oregon, USA
⁴ University of Florida, Gainesville, Florida, USA
⁵ St. Luke’s/Roosevelt Hospital, New York, New York, USA
⁶ Beaumont Hospital, Dublin, Ireland
⁷ University of Nebraska, Omaha, Nebraska, USA
⁸ University of California, San Francisco, California, USA
⁹ University of Texas at Tyler, Tyler, Texas, USA
¹⁰ Cleveland Clinic, Cleveland, Ohio, USA
¹¹ Medical University of South Carolina, Charlottesville, South Carolina, USA
¹² University of Utah, Salt Lake City, Utah, USA

Correspondence to:
Correspondence to:
Dr Dawn L DeMeo
Channing Laboratory, 181 Longwood Avenue, Boston, Massachusetts 02115, USA; dawn.demeo{at}channing.harvard.edu

ABSTRACT
Background: Severe ₁-antitrypsin (AAT) deficiency is an autosomal recessive genetic condition associated with an increased but variable risk for chronic obstructive pulmonary disease (COPD). A study was undertaken to assess the impact of chronic bronchitis, pneumonia, asthma and sex on the development of COPD in individuals with severe AAT deficiency.

Methods: The AAT Genetic Modifier Study is a multicentre family-based cohort study designed to study the genetic and epidemiological determinants of COPD in AAT deficiency. 378 individuals (age range 33–80 years), confirmed to be homozygous for the SERPINA1 Z mutation, were included in the analyses. The primary outcomes of interest were a quantitative outcome, forced expiratory volume in 1 s (FEV₁) percentage predicted, and a qualitative outcome, severe airflow obstruction (FEV₁ <50% predicted).

Results: In multivariate analysis of the overall cohort, cigarette smoking, sex, asthma, chronic bronchitis and pneumonia were risk factors for reduced FEV₁ percentage predicted and severe airflow obstruction (p<0.01). Index cases had lower FEV₁ values, higher smoking histories and more reports of adult asthma, pneumonia and asthma before age 16 than non-index cases (p<0.01). Men had lower pre- and post-bronchodilator FEV₁ percentage predicted than women (p<0.0001); the lowest FEV₁ values were observed in men reporting a history of childhood asthma (26.9%). This trend for more severe obstruction in men remained when index and non-index groups were examined separately, with men representing the majority of non-index individuals with airflow obstruction (71%). Chronic bronchitis (OR 3.8, CI 1.8 to 12.0) and a physician’s report of asthma (OR 4.2, CI 1.4 to 13.1) were predictors of severe airflow obstruction in multivariate analysis of non-index men but not women.

Conclusion: In individuals with severe AAT deficiency, sex, asthma, chronic bronchitis and pneumonia are risk factors for severe COPD, in addition to cigarette smoking. These results suggest that, in subjects severely deficient in AAT, men, individuals with symptoms of chronic bronchitis and/or a past diagnosis of asthma or pneumonia may benefit from closer monitoring and potentially earlier treatment.

Abbreviations: AAT, ₁-antitrypsin; COPD, chronic obstructive pulmonary disease; FEV₁, forced expiratory volume in 1 s; FVC, forced vital capacity

This article has been cited by other articles:

				G. M Turino COPD and biomarkers: the search goes on Thorax, December 1, 2008; 63(12): 1032 - 1034. [Full Text] [PDF]

				D. L. DeMeo, E. J. Campbell, A. F. Barker, M. L. Brantly, E. Eden, N. G. McElvaney, S. I. Rennard, R. A. Sandhaus, J. M. Stocks, J. K. Stoller, et al. IL10 Polymorphisms Are Associated with Airflow Obstruction in Severe {alpha}1-Antitrypsin Deficiency Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 114 - 120. [Abstract] [Full Text] [PDF]